Vasomodulating function of the endothelium in hemorrhagic fever with renal syndrome

Abstract

Aim. To study the content of endothelin-1, nitric oxide (II) and the activity of angiotensin-converting enzyme in the blood of patients with hemorrhagic fever with renal syndrome, depending on the period and the severity of the disease in order to assess their role in the pathogenesis and to develop a pathogenetically substantiated correction of the changes in the systemic vascular tone. Methods. The group of dynamic study included 114 patients (102 male and 12 female) with serologically confirmed hemorrhagic fever with renal syndrome aged 22-55 years. The moderately severe form was diagnosed in 66 patients, severe uncomplicated form - in 27, severe form with complications - in 21 patients. The control group comprised 23 practically healthy volunteers. The concentration of endothelin-1 in blood plasma, the contents of metabolic products of nitric oxide (II) and the activity of the angiotensin-converting enzyme in the blood serum were determined. Results. The concentration of endothelin-1 in the blood in the dynamics of the disease significantly decreased, the content of the final stable metabolites of nitric oxide (II) and the activity of the angiotensin-converting enzyme increased with statistical significance in all periods of the disease. These changes were most pronounced during severe forms of the disease with complications. Conclusion. In moderately severe and severe uncomplicated forms of the disease the endothelium is able to maintain the systemic vascular tone and tissue perfusion at a physiological level, however in severe form with complications the changes in the synthesis of vasomodulating substances may be involved in the development of complications.

Keywords

endothelin-1 / nitric oxide (II) / angiotensin-converting enzyme / hemorrhagic fever with renal syndrome

References

[1] Байгильдина А.А., Лебедева А.И., Вагапова В.Ш. Возможные источники циркулирующих в крови эндотелиальных клеток // Морфология. - 2011. - Т. 139, №3. - С. 58-62.

[2] Сиротин Б.З. Геморрагическая лихорадка с почечным синдромом. - Хабаровск: Хабаровская краевая типография, 1994. - 300 с.

[3] Akaike T., Maeda H. Nitric oxide and virus infection // Immunology. - 2000. - Vol. 101. - P. 300-308.

[4] Alonso D., Radomski M.W. The nitric oxide - endothelin-1 connection // Heart Fail. Rev. - 2003. - Vol. 8. - P. 107-118.

[5] Baumgartner-Parzer S.M., Waldhausl W.K. The endothelium as a metabolic and endocrine organ: its relation with insulin resistance // Exp. Clin. Endocrinol. Diabetes. - 2001. - Vol. 109. - P. 166-179.

[6] Furusu F., Miyazaki M., Abe K. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis // Kidney Int. - 1998. - Vol. 53, N 6. - P. 1760-1768.

[7] Iglarz M., Clozel M. Mechanisms of ET-1-induced endothelial dysfunction // J. Cardiovasc. Pharmacol. - 2007. - Vol. 50. - P. 621-628.

[8] Jiang L., Guo H., Fang D. Effect of dengue virus infection on the production of ET-1 and PGI2 by human vascular endothelial cells // Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. - 1999. - Vol. 13. - P. 239-242.

[9] Neves-Souza P.C., Azeredo E.L., Zagne S.M. et al. Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue fever in patients and during in vitro infection // BMC Infect. Dis. - 2005. - Vol. 5. - P. 64-69.

[10] Peters C.J., Zaki S.R. Role of the endothelium in viral hemorrhagic fevers // Crit. Care Med. - 2002. - Vol. 30, N 5. - P. 268-273.

[11] Shao J., Miyata T., Yamada K. et al. Protective role of nitric oxide in model of thrombotic microangiopathy in rats // J. Am. Soc. Nephrol. - 2001. - Vol. 12. - P. 2088-2097.

[12] Takhampunya R., Padmanabhan R., Ubol S. Antiviral action of nitric oxide on dengue virus type 2 replication // J. Gen. Virol. - 2006. - Vol. 87, N 10. - P. 3003-3011.

[13] Valbuena G., Walker D.H. The endothelium as a target for infections // Annu. Rev. Pathol. - 2006. - Vol. 1, N 1. - P. 171-198.

[14] Widlansky M.E., Gokce N., Keaney J.F., Vita J.A. The clinical implications of endothelial dysfunction // J. Am. Coll. Cardiol. - 2003. - Vol. 42. - P. 1149-1160.

[15] Zhou M.S., Schulman I.H., Raij L. Nitric oxide, angiotensin II and hypertension // Semin. Nephrol. - 2004. - Vol. 24. - P. 366-378.

RIGHTS & PERMISSIONS

Baygildina A.A.